Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309722969> ?p ?o ?g. }
- W4309722969 abstract "Abstract Aims Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a clinical entity with several causes and pathophysiologic mechanisms. Secondary prevention with medical therapy used in patients with obstructive coronary artery disease has unclear benefits in MINOCA patients. Methods and results A literature search was conducted until 8 March 2022. Random-effect frequentist and hierarchical Bayesian meta-analyses were performed to assess the clinical impact of medical therapy [renin–angiotensin–aldosterone system (RAAS) inhibitors, statins, dual antiplatelet therapy (DAPT), β-blockers] in MINOCA patients. Outcomes of interest were all-cause mortality and major adverse cardiovascular events (MACE). A total of 12 663 MINOCA patients among five observational studies were analysed. The mean follow-up ranged from 12 to 90 months across studies. In frequentist meta-analysis, statins and β-blockers were associated with a lower risk of all-cause mortality [pooled adjusted hazard ratios (aHRs) 0.53 and 0.81, with 95% confidence intervals (CIs) (0.37–0.76) and (0.67–0.97), respectively]. Only RAAS inhibitors were associated with a lower risk of MACE [pooled aHR: 0.69, with 95% CI (0.53–0.90)]. Bayesian meta-analysis based on informative prior assumptions offered strong evidence only for the benefit of statins on decreasing the risk of all-cause death [Bayes factor (BF): 33.2] and moderate evidence for the benefit of RAAS inhibitors on decreasing the risk of MACE (BF: 9); assigning less informative prior distributions did not affect the results, yet it downgraded the level of evidence to anecdotal. Conclusion In this meta-analysis, statins and RAAS inhibitors were consistently associated with a lower risk of all-cause mortality and MACE, respectively, in patients with MINOCA. Neutral prognostic evidence was demonstrated for β-blockers and DAPT." @default.
- W4309722969 created "2022-11-29" @default.
- W4309722969 creator A5003352897 @default.
- W4309722969 creator A5004408075 @default.
- W4309722969 creator A5004790580 @default.
- W4309722969 creator A5031131640 @default.
- W4309722969 creator A5045803379 @default.
- W4309722969 creator A5053464595 @default.
- W4309722969 creator A5056041904 @default.
- W4309722969 creator A5063154767 @default.
- W4309722969 creator A5065787663 @default.
- W4309722969 creator A5074737994 @default.
- W4309722969 creator A5079933234 @default.
- W4309722969 creator A5081362182 @default.
- W4309722969 creator A5084577058 @default.
- W4309722969 creator A5088290603 @default.
- W4309722969 creator A5088712364 @default.
- W4309722969 date "2022-11-01" @default.
- W4309722969 modified "2023-10-07" @default.
- W4309722969 title "Prognostic impact of secondary prevention medical therapy following myocardial infarction with non-obstructive coronary arteries: a Bayesian and frequentist meta-analysis" @default.
- W4309722969 cites W1553345686 @default.
- W4309722969 cites W1964206499 @default.
- W4309722969 cites W1980092314 @default.
- W4309722969 cites W1987468165 @default.
- W4309722969 cites W1995641184 @default.
- W4309722969 cites W2009872720 @default.
- W4309722969 cites W2074779415 @default.
- W4309722969 cites W2119929689 @default.
- W4309722969 cites W2135262484 @default.
- W4309722969 cites W2165010366 @default.
- W4309722969 cites W2170552632 @default.
- W4309722969 cites W2234845577 @default.
- W4309722969 cites W2343657979 @default.
- W4309722969 cites W2395427622 @default.
- W4309722969 cites W2509575626 @default.
- W4309722969 cites W2519634482 @default.
- W4309722969 cites W2586296716 @default.
- W4309722969 cites W2611589877 @default.
- W4309722969 cites W2729627448 @default.
- W4309722969 cites W2747892463 @default.
- W4309722969 cites W2754985403 @default.
- W4309722969 cites W2758634927 @default.
- W4309722969 cites W2772013107 @default.
- W4309722969 cites W2805117454 @default.
- W4309722969 cites W2888543854 @default.
- W4309722969 cites W2889884522 @default.
- W4309722969 cites W2899755710 @default.
- W4309722969 cites W2925239642 @default.
- W4309722969 cites W2941452847 @default.
- W4309722969 cites W2942478007 @default.
- W4309722969 cites W2956109164 @default.
- W4309722969 cites W2960427799 @default.
- W4309722969 cites W3004390928 @default.
- W4309722969 cites W3015426746 @default.
- W4309722969 cites W3025239287 @default.
- W4309722969 cites W3102078311 @default.
- W4309722969 cites W3109181954 @default.
- W4309722969 cites W3113309573 @default.
- W4309722969 cites W3118615836 @default.
- W4309722969 cites W3121592627 @default.
- W4309722969 cites W3127099019 @default.
- W4309722969 cites W3162195278 @default.
- W4309722969 cites W3174366578 @default.
- W4309722969 cites W3211740949 @default.
- W4309722969 cites W4225774957 @default.
- W4309722969 cites W4238277289 @default.
- W4309722969 cites W4292255191 @default.
- W4309722969 doi "https://doi.org/10.1093/ehjopen/oeac077" @default.
- W4309722969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36523547" @default.
- W4309722969 hasPublicationYear "2022" @default.
- W4309722969 type Work @default.
- W4309722969 citedByCount "2" @default.
- W4309722969 countsByYear W43097229692023 @default.
- W4309722969 crossrefType "journal-article" @default.
- W4309722969 hasAuthorship W4309722969A5003352897 @default.
- W4309722969 hasAuthorship W4309722969A5004408075 @default.
- W4309722969 hasAuthorship W4309722969A5004790580 @default.
- W4309722969 hasAuthorship W4309722969A5031131640 @default.
- W4309722969 hasAuthorship W4309722969A5045803379 @default.
- W4309722969 hasAuthorship W4309722969A5053464595 @default.
- W4309722969 hasAuthorship W4309722969A5056041904 @default.
- W4309722969 hasAuthorship W4309722969A5063154767 @default.
- W4309722969 hasAuthorship W4309722969A5065787663 @default.
- W4309722969 hasAuthorship W4309722969A5074737994 @default.
- W4309722969 hasAuthorship W4309722969A5079933234 @default.
- W4309722969 hasAuthorship W4309722969A5081362182 @default.
- W4309722969 hasAuthorship W4309722969A5084577058 @default.
- W4309722969 hasAuthorship W4309722969A5088290603 @default.
- W4309722969 hasAuthorship W4309722969A5088712364 @default.
- W4309722969 hasBestOaLocation W43097229691 @default.
- W4309722969 hasConcept C107673813 @default.
- W4309722969 hasConcept C126322002 @default.
- W4309722969 hasConcept C154945302 @default.
- W4309722969 hasConcept C160234255 @default.
- W4309722969 hasConcept C162376815 @default.
- W4309722969 hasConcept C164705383 @default.
- W4309722969 hasConcept C207103383 @default.
- W4309722969 hasConcept C2776820930 @default.
- W4309722969 hasConcept C2778213512 @default.
- W4309722969 hasConcept C2778742706 @default.